Skip to main content
Paul Shinn on Muck Rack

Paul Shinn

As seen in: Nature, BioRxiv, Enid News and Eagle, OK Policy Blog, Oklahoma Observer, The Madill Record
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance

|
By Wei Zhou, Wei Sun, Sheng Dai, Yihua Cai, Chi-Wei Chen, Yunxiao Meng, Jennifer Lee, John Braisted, Yinghua Xu, Noel Southall, Paul Shinn, Xuefeng Huang, Zhangfa Song, Xiulei Chen, Yan Kai, Xin Cai, Qiang Hao, Stephanie Liu Verified, Stephanie Barak, Jing Hao, Zhijun Dai, Weiqun Peng, Huadong Pei, Zhiyong Han, David Chan, Wei Zheng, Wenge Zhu, Mingo M. H. Yung, Zongzhu Li, Annie N. Y. Cheung, Hextan Y. S. Ngan, Alexandros Tzatsos
| Nature Verified
Correction to: Oncogene https://doi.org/10.1038/s41388-018-0238-8, published online 17 April 2018 Following the publication of this article, the authors noted two inadvertent errors in Figure 5c, which occurred during figure assembly. The JAK2 immunoblot was mistakenly used in place of the STAT5 immunoblot, and the GAPDH loading control was inadvertently taken from a different blot generated from the same cell lysates. The corrected Figure 5c is provided below.
Open in Who Shared Issue with article?

A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug Discovery

|
By Xin Hu, Paul Shinn, Zina Itkin, Ye Lin
| BioRxiv
Abstract As part of the NIH Helping to End Addiction Long-term (HEAL) Initiative, the National Center for Advancing Translational Sciences (NCATS) is dedicated to the development of new pharmacological tools and investigational drugs for managing and treating pain, as well as the prevention and treatment of opioid misuse and addiction.
Open in Who Shared Issue with article?

A comprehensive collection of pain and addiction targets and compounds library for high throughput screening and AI-driven drug discovery

|
By Xin Hu, Paul Shinn, Zina Itkin, Ye Lin
| BioRxiv
Abstract As part of the NIH Helping to End Addiction Long-term (HEAL) Initiative, the National Center for Advancing Translational Sciences (NCATS) is dedicated to the development of new pharmacological tools and investigational drugs for managing and treating pain, as well as the prevention and treatment of opioid misuse and addiction.
Open in Who Shared Issue with article?
See all 13 articles